medline.ch Gynäkologie Mammae

	Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER). Ann Oncol Kalinsky K, Barlow WE, Pathak HB, Puri RV, Mitra A, Home T, Gralow J, Albain KS, Hayes DF, Delaloge S, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Rastogi P, Schott AF, Brain E, Pierga JY, Ferrero JM, Shak S, Tripathy D, Hortobagyi GN, Meric-Bernstam F, Sharma P, Pusztai L, Thompson A, Godwin AK. PMID: 42613139 [PubMed - indexed for MEDLINE]
	The role of chimeric antigen receptor (CAR) T cell therapy in breast cancer. Int Immunopharmacol Farajzadeh A, Mahmoudi M, Yazdani S, Barati AM, Kheder RK, Rostami O, Fadaee A, Raouf-Rahmati A, Esmaeili SA. PMID: 42612349 [PubMed - as supplied by publisher]
	Potential small-molecule tyrosine kinase inhibitors (TKIs) for the treatment of triple-negative breast cancer (TNBC): Targets, structure-activity relationships, and clinical studies. Eur J Med Chem Yuan H, Li H, Zhou Y, He Z, Yang S, Wang L, He Y, Li L, Yu D, Shi J. PMID: 42612290 [PubMed - as supplied by publisher]
	Construction of Human Breast Cancer Organoids and Comet Assay-Based Quantification of Doxorubicin-Induced DNA Damage. J Vis Exp Wu Y, Jin Z, Du J, Li L, Ouyang W, Yin L, Zhao S, Li J, Li X, Liu SB. PMID: 42612119 [PubMed - indexed for MEDLINE]
	Comprehensive Analysis of m6A Regulators Identifies YTHDF3 as a Promising Prognostic Biomarker for Breast Cancer. J Vis Exp Jin P, Fan Y. PMID: 42612048 [PubMed - indexed for MEDLINE]
	Advancing Evidence of the Associations between specific Benign Breast Diagnoses and Future Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev Sattayapiwat O, Weaver DL, Borowsky AD, Keegan THM, Sprague BL, Kerlikowske K, Miglioretti DL. PMID: 42611528 [PubMed - as supplied by publisher]
	Long-Term Fatigue After Treatment for Breast Cancer. JAMA Netw Open Avis NE, O'Connell NS, Mihalko SL, Jordan JH, Ladd AC, Lesser GJ, Olson KC, Weaver KE, Dressler EV, Grizzard PJ, Levine B, Moore TL, Ky B, Hackney MH, Brubaker P, Reding KW, Lucas AR, Bellissimo MP, Moeller FG, Kitzman DW, Hamilton CA, Klepin HD, Yeboah J, Ntim W, Zaha VG, D'Agostino R Jr, Hundley WG. PMID: 42611514 [PubMed - indexed for MEDLINE]
	Preoperative MRI versus Ultrasound in Axillary Nodal Staging in Breast Cancer: Additive Role of MRI. J Breast Imaging Arjmandi FK, Ozcan BB, Hu T, Froix A, McArthur H, Xi Y, Dogan BE. PMID: 42611512 [PubMed - as supplied by publisher]
	THBS2: the key hub linking breast cancer stroma, immunity, and therapeutic response. Clin Exp Metastasis Wan X, Zhao X, Lin Y, Yang S, Dai H, Li Y, Wang X. PMID: 42611356 [PubMed - indexed for MEDLINE]
	Factors influencing decision regret regarding contralateral prophylactic mastectomy in women at high risk of hereditary breast cancer: a cross-sectional study. Support Care Cancer Park SY, Kim Y. PMID: 42611345 [PubMed - indexed for MEDLINE]
	Nanoparticles for fluorescence-guided breast cancer surgery: advances in in vivo preclinical research. Nanomedicine (Lond) Zahraie N, Chivu A, MacRobert AJ, Patra H, Yaghini E. PMID: 42610677 [PubMed - as supplied by publisher]
	Highly Efficient Homologous Targeting Magnetic Resonance Imaging Probe for Enhanced T1 Contrast Imaging of Triple-Negative Breast Cancer by Deactivated Tumor Cell-Loaded Manganese Carbonate. ACS Appl Bio Mater Wang P, Xia J, Wang H, Liu Q, Gao W, Zhang G. PMID: 42610464 [PubMed - as supplied by publisher]
	AI-driven CRISPR strategies in breast cancer: Organoid modeling, adaptive editing, and precision delivery. Iran J Basic Med Sci Taki AG, Shareef A, Arora V, Oweis R, Jyothi SR, Singh U, Sahoo S, Chauhan AS, Klebleeva G, Sameer HN, Yaseen A, Athab ZH, Adil M. PMID: 42610144 [PubMed]
	Mobile-Health Intervention on Body Image Fear and Fatigue in Women with Breast Cancer: A Randomized Controlled Trial. Iran J Nurs Midwifery Res Behroozian A, Shakerian S. PMID: 42610120 [PubMed]
	Correction: Integrating multi-omics data reveals IL-8 positive cancer-associated fibroblasts as mediators of chemotherapy-induced tumor progression in breast cancer. Front Immunol Liao H, Li H, Song J, Dong J, Bai X. PMID: 42609966 [PubMed - in process]
	Evaluating federated learning approaches for mammography under breast density heterogeneity. J Med Imaging (Bellingham) Quintana GI, Di Maria FM, Vancamberg L. PMID: 42609931 [PubMed]
	Artificial intelligence standardizes CT-based body composition analysis in breast cacer to address methodological heterogeneity. Front Oncol Duan W, Wang R. PMID: 42609826 [PubMed]
	miR-1246 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Breast Cancer: A Narrative Review With Pharmacoeconomic Perspectives. Health Sci Rep Ghaith A, Hussein LA. PMID: 42609748 [PubMed]
	Clinical Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy for Triple-Negative Breast Cancer and Tumor Immune Microenvironment Analysis: A Prospective-Retrospective Cohort Study. MedComm (2020) Wang Y, Qiu P, Wang Y, Meng X, Zhang J, Liu H, Shi Z, Zhang Z, Sun X, Wang C, Meng X, Zheng C. PMID: 42609520 [PubMed]
	Biomarker testing in advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2 negative breast cancer: expert recommendations. Ther Adv Med Oncol Reinert T, Alshehri AS, Shafik A, Lin CH, Gomez Abuin G, Gong G, Jung KH, Amat M, Pathmanathan N, Ow SGW, Rivera-Rivera S, Aggarwal S, Luen SJ, Yong Tay TK. PMID: 42609450 [PubMed]

Artikel 1 - 20 / 221222

Seite 1 von 11062

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung